Dalbavancin is under clinical development by AbbVie and currently in Phase III for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. According to GlobalData, Phase III drugs for ...

Anterior Cruciate Ligament Reconstruction Improves Functional Scores and Quality of Life in Patients Older than 50 Years of ...

Clinical Efficacy of Ceftazidime/avibactam Combination Therapy for Severe Hospital-acquired Pulmonary Infections Caused by Carbapenem-Resistant and Difficult-to-Treat Pseudomonas aeruginosa.

Table 1. SNPs involving in the development of bone and joint infections. This comprehensive review encapsulates the current evidence pertaining to the associations between SNPs of diverse genes and ...

Its veterinary drugs include seramectin, telavancin hydrochloride, emodes, doramectin and dalbavancin. The company develops products in the therapeutic areas of cardiology, oncology, antibacterial, ...

Purpose. The chemistry, pharmacology, antimicrobial activity, pharmacokinetics, pharmacodynamics, efficacy and safety in humans, and formulary considerations of doripenem are reviewed. Summary ...

Department of Chemistry, University of California─Irvine, Irvine, California 92697, United States Department of Pharmaceutical Sciences, University of California─Irvine, Irvine, California 92697, ...